Summary
Malignant gliomas are the most common and devastating primary tumors of the central nervous system. Currently no efficient treatment is available. This study evaluated the effect and underlying mechanisms of boldine, an aporphine alkaloid of Peumus boldus, on glioma proliferation and cell death. Boldine decreased the cell number of U138-MG, U87-MG and C6 glioma lines at concentrations of 80, 250 and 500 μM. We observed that cell death caused by boldine was cell-type specific and dose-dependent. Exposure to boldine for 24 h did not activate key mediators of apoptosis. However, it induced alterations in the cell cycle suggesting a G2/M arrest in U138-MG cells. Boldine had no toxic effect on non-tumor cells when used at the same concentrations as those used on tumor cells. Based on these results, we speculate that boldine may be a promising compound for evaluation as an anti-cancer agent.
Similar content being viewed by others
References
Aygeropoulos NG, Batchelor TT (1999) New treatment strategies for malignant gliomas. Oncologist 4:209–224
Davis FG, McCarthy BJ, Freels S (1999) The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85:85–491, doi:10.1002/(SICI)1097-0142(19990101)85:1<85::AID-CNCR12>3.0.CO;2-A
Maher EA, Furnari FB, Bachoo RM et al (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311–1333, doi:10.1101/gad.891601
Weller M, Fontana A (1995) The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev 21:128–151, doi:10.1016/0165-0173(95)00010-0
Trog D, Fountoulakis M, Friedlein A et al (2006) Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions. Proteomics 6:2924–2930, doi:10.1002/pmic.200500587
Phillipson JD (2001) Phytochemistry and medicinal plants. Phytochemistry 56:237–243, doi:10.1016/S0031-9422(00)00456-8
Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66:1022–1037, doi:10.1021/np030096l
Stévigny C, Bailly C, Quetin-Leclercq J (2005) Cytotoxic and antitumour potentialities of aporphinoid alkaloids. Curr Med Chem Anti-Canc Agents 5:173–182
Hidalgo ME, Farah M, Carrasco L et al (2005) Photostability and photoprotection factor of boldine and glaucine. J Photochem Photobiol B 80:65–69, doi:10.1016/j.jphotobiol.2005.01.005
Speisky H, Cassels BK, Lissi E et al (1991) Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation. Biochem Pharmacol 41:1575–1581, doi:10.1016/0006-2952(91)90156-Y
Martínez J, Ríos L, Payá M et al (1992) Inhibition of non-enzymic lipid peroxidation by benzylisoquinoline alkaloids. Free Radic Biol Med 12:287–292, doi:10.1016/0891-5849(92)90116-X
Cederbaum A, Kikielka E, Speisky H (1992) Inhibition of rat liver microsomal lipid peroxidation by boldine. Biochem Pharmacol 44:1765–1772, doi:10.1016/0006-2952(92)90070-Y
Lanhers MC, Joyeux M, Soulimani R et al (1991) Hepatoprotective and anti-inflammatory effects of a traditional medicinal plant of Chile, Peumus boldus. Planta Med 57:110–115, doi:10.1055/s-2006-960043
Hoet S, Stévigny C, Block S et al (2004) Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases. Planta Med 70:407–413, doi:10.1055/s-2004-818967
Skehan P, Storeng R, Scudiero D et al (1990) New colorimetric cytotoxicity assay for anti-cancer-drug screening. J Natl Cancer Inst 82:1107–1112, doi:10.1093/jnci/82.13.1107
Bernardi A, Jacques-Silva MC, Delgado-Cañedo A et al (2006) Nonsteroidal anti-inflamatory drugs inhibit the growth of C6 and U138-MG glioma cell lines. Eur J Pharmacol 532:214–222, doi:10.1016/j.ejphar.2006.01.008
Overton WR, McCoy JP Jr (1994) Reversing the effect of formalin on the binding of propidium iodide to DNA. Cytometry 16:351–356, doi:10.1002/cyto.990160410
Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173–182, doi:10.1016/0165-0270(91)90128-M
Valentim LM, Rodnight R, Geyer AB (2003) Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 118:379–386, doi:10.1016/S0306-4522(02)00919-3
Horn AP, Gerhardt D, Geyer AB (2005) Cellular death in hippocampus in response to PI3-K pathway inhibition and oxygen and glucose deprivation. Neurochem Res 30:355–361, doi:10.1007/s11064-005-2609-0
Tsuiki H, Nitta M, Tada M (2001) Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene 20:420–429, doi:10.1038/sj.onc.1204126
Hartmann A, Speit G (1997) The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol Lett 90:183–188, doi:10.1016/S0378-4274(96)03847-7
Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261, doi:10.1385/MB:26:3:249
Zhang W, Fei Z, Zhen H et al (2007) Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J Neurooncol 81:231–240, doi:10.1007/s11060-006-9226-x
Liu X, Wang J, Sun B et al (2007) Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803. Invest New Drugs 25:505–517, doi:10.1007/s10637-007-9057-4
Van den Bent MJ, Hegi ME, Stupp R (2006) Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 42:582–588, doi:10.1016/j.ejca.2005.06.031
Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619–642, doi:10.1146/annurev.physiol.60.1.619
Morgan DO (1995) Principles of cdk regulation. Nature 374:131–134, doi:10.1038/374131a0
Dirks PB, Rutka JT (1997) Current concepts in neuro-oncology: the cell cycle—a review. Neurosurgery 40:1000–1013, doi:10.1097/00006123-199705000-00025
Fiers W, Beyaert R, Declercq W et al (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18:7719–7730, doi:10.1038/sj.onc.1203249
Borner C, Monney L (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 6:497–507, doi:10.1038/sj.cdd.4400525
Mochizuki T, Asai A, Saito N et al (2002) Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide. J Biol Chem 277:2790–2797, doi:10.1074/jbc.M106361200
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776, doi:10.1038/35037710
Chandna S (2004) Single-cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death. Cytometry A 61:127–133, doi:10.1002/cyto.a.20071
Trog D, Moenkemann H, Breipohl W et al (2007) Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions. Amino Acids 32:373–379, doi:10.1007/s00726-006-0456-1
Acknowledgments
This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). The authors thank Alessandra Heizelmann for the excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gerhardt, D., Horn, A.P., Gaelzer, M.M. et al. Boldine: a potential new antiproliferative drug against glioma cell lines. Invest New Drugs 27, 517–525 (2009). https://doi.org/10.1007/s10637-008-9203-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-008-9203-7